Pricing
  1. JP-listed companies
  2. JMS CO.,LTD.
  3. Financials
  4. Total cash & short-term investments

JMS CO.,LTD.【JP:7702】

Market cap
¥10.7B
P/E ratio
-13.3x
JMS manufactures and sells medical devices and pharmaceuticals globally, serving healthcare markets across Asia, Europe and the Americas.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndTotal cash & short-term investments (Million JPY)YoY (%)
Mar 31, 20255,511-46.54%
Mar 31, 202410,308+62.87%
Mar 31, 20236,329-7.10%
Mar 31, 20226,813+9.46%
Mar 31, 20216,224+3.41%
Mar 31, 20206,019-16.75%
Mar 31, 20197,230-0.04%
Mar 31, 20187,233+14.07%
Mar 31, 20176,341+5.97%
Mar 31, 20165,984+27.02%
Mar 31, 20154,711

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)